Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia

Jen, Joanna C.; Qing Yue; Karrim, Juliana; Nelson, Stanley F.; Baloh, Robert W.; Jen, J C; Yue, Q; Karrim, J; Nelson, S F; Baloh, R W
October 1998
Journal of Neurology, Neurosurgery & Psychiatry;Oct1998, Vol. 65 Issue 4, p565
Academic Journal
journal article
No abstract available.


Related Articles

  • Spinocerebellar ataxia type 17 in a patient from an Indian kindred. Haubenberger, Dietrich; Prayer, Daniela; Bauer, Peter; Pirker, Walter; Zimprich, Alexander; Auff, Eduard // Journal of Neurology;Nov2006, Vol. 253 Issue 11, p1513 

    A letter to the editor on spinocerebellar ataxia type 17 is presented.

  • Aggravation of ataxia due to ocetazolamide induced hyperammonaemia in episodic ataxia. Jeong-Min Kim; Wi-Sun Ryu; Young-Hwan Hwang; Ji Soo Kim // Journal of Neurology, Neurosurgery & Psychiatry;Jul2007, Vol. 78 Issue 7, p771 

    A letter to the editor is presented in response to the article about the case of man with acetazolamide induced hyperammonemia in episodic ataxia.

  • Inherited ataxia with slow saccades. Chakor, R. T.; Bharote, H. // Journal of Postgraduate Medicine;Oct-Dec2012, Vol. 58 Issue 4, p318 

    Ataxia is a symptom of cerebellar dysfunction. Slowly progressive ataxia, dysarthria in an adult with a positive family history suggests an inherited cerebellar ataxia. We present an adult with gradually progressive ataxia and slow saccades. There was history of similar illness in his son....

  • Predisposing chromosome for spinocerebellar ataxia type 6 (SCA6) in Japanese. Yabe, I.; Sasaki, H.; Yamashita, I.; Tashiro, K.; Takei, A.; Suzuki, Y.; Kida, H.; Takiyama, Y.; Nishizawa, M.; Hokezu, Y.; Nagamatsu, K.; Oda, T.; Ohnishi, A.; Inoue, I.; Hata, A. // Journal of Medical Genetics;May2001, Vol. 38 Issue 5, p328 

    Presents a letter to the editor about the chromosome for spinocerebellar ataxia type 6.

  • Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype. van de Warrenburg, B. P. C.; Frenken, C. W. G. M.; Ausems, M. G. E. M.; Kleefstra, T.; Sinke, R. J.; Knoers, N. V. A. M.; Kremer, H. P. H. // Journal of Neurology;Oct2001, Vol. 248 Issue 10, p911 

    Presents a letter to the editor concerning striking anticipation in spinocerebellar ataxia type 7.

  • Large de novo expansion of CAG repeats in patient with sporadic spinocerebellar ataxia type 7. Bauer, Peter; Kraus, Josef; Matoska, Vaclav; Brouckova, Martina; Zumrova, Alena; Goetz, Petr // Journal of Neurology;Aug2004, Vol. 251 Issue 8, p1023 

    Presents a letter to the editor on causes of spinocerebellar ataxia type 7.

  • Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q. Cha, Y. H.; Lee, H.; Jen, J. C.; Kattah, J. C.; Nelson, S. F.; Baloh, R. W. // Journal of Neurology, Neurosurgery & Psychiatry;Nov2007, Vol. 78 Issue 11, p1273 

    We describe four families with late onset episodic vertical oscillopsia and progressive gait ataxia. Probands presented between the ages of 40 and 64 years with initial symptoms of episodic vertical oscillopsia and interictal downbeat nystagmus. A mild gait ataxia developed over several years....

  • Novel splice site CACNA1A mutation causing episodic ataxia type 2. Kaunisto, M. A.; Harno, H.; Kallela, M.; Somer, H.; Sallinen, R.; Hämäläinen, E.; Miettinen, P. J.; Vesa, J.; Orpana, A.; Palotie, A.; Färkkilä, M.; Wessman, M. // Neurogenetics;Feb2004, Vol. 5 Issue 1, p69 

    Episodic ataxia type 2 (EA-2) is an autosomal dominant neurological disorder, characterized by episodes of ataxia, vertigo, nausea, nystagmus, and fatigue, associated with acetazolamide responsiveness. The disease is caused by mutations in the P/Q-type calcium channel Cav2.1 subunit gene,...

  • New blood test detects type of ataxia.  // Brown University Long-Term Care Quality Advisor;01/13/97, Vol. 9 Issue 1, p3 

    Reports on the discovery of the genetic defect responsible for spino-cerebellar ataxia type two. Estimated number of people affected by the disease in the United States. Other forms of ataxia.

  • CACNA1A Mutation in a EA-2 Patient Responsive to Acetazolamide and Vaiproic Acid. Scoggan, Kylie A.; Friedman, Joseph H.; Bulman, Dennis E. // Canadian Journal of Neurological Sciences;Feb2006, Vol. 33 Issue 1, p68 

    The article presents a study on CACNA1A mutation in an episodic ataxia type-2 (EA-2) patient and its response to acetazolamide and valproic acid. EA-2 is an autosomal dominant neurological disorder resulting from mutation in the CACNA1A gene encoding the P/Q-type calcium channel. Patients...


Read the Article


Sign out of this library

Other Topics